Functional Medicine and Healthspan: Keeping the Goals Clear

How do healthspan and lifespan differ?

Healthspan is about health and useful function during life. Lifespan is about how long life lasts. They are linked, but they are not the same measure. A study may show a change in one aspect of health without showing that people live longer. Ask what a plan aims to do for you. Keep that aim clear when you read its claims and look at the evidence.

Think about what ageing well means to you. It may mean keeping up a valued activity, managing a known condition or reducing a specific risk. Those goals can guide a conversation more clearly than a general wish to optimise every test result.

Ask if the outcome in an advertisement matches the outcome in its evidence. A change in a blood marker, a questionnaire score and survival are different findings. They should not be collapsed into a single promise of longevity.

For this part of the discussion, see evidence-based priorities for healthy ageing.

For this part of the discussion, see which healthy-ageing biomarkers are actionable.

Where do symptom care and prevention overlap?

An visit may talk about both current symptoms and future risk. But they remain distinct questions. A symptom needs suitable review. Prevention asks what can reduce the chance of later problems. Neither should be lost in a broad programme that promises to address all health concerns at once.

Long-term diabetes-prevention research concerns people selected for elevated diabetes risk. It can inform prevention questions in that context. But it is not evidence that every wellness package extends life. The population and the actual outcome need to remain part of the claim. [2]

If you already have a condition, keep its care plan central. Ask how any new advice fits with treatment and follow-up. A focus on future health should not distract from effective care now or encourage you to stop prescribed treatment without review.

Which established priorities still matter?

Established prevention includes attention to relevant risk factors and recommended care, rather than only novel tests. Cardiovascular guidance, for example, considers smoking, blood pressure, cholesterol and other factors, with daily habits and medicines where needed. These priorities should not be displaced by a more fashionable biomarker. [3]

The Private Health Screening and Preventive Assessment page explains preventive review. Ask which actions are suitable for your age, history and current health, and which have the clearest evidence. A useful plan can be modest and focused rather than a large package of investigations.

Practical support matters too. A piece of advice that cannot fit your mobility, budget or daily responsibilities may need to change. Explain what you can sustain and what help you would need. The aim is a plan you can use, not a test of how strictly you can follow a programme.

How should newer tests and interventions be judged?

Ask what has been measured in humans and if the finding matters to patients. Laboratory mechanisms and animal studies can be valuable early research. They do not, on their own, show that an approach makes people healthier for longer.

The CALERIE analysis studied changes in DNA-methylation measures after calorie restriction. It is an example of research on ageing-related markers, not proof that a commercial biological-age test or restrictive diet extends a person's lifespan. [4]

Before paying for a test, ask how its result would change care. If the advice would be the same regardless of the score, the test may not add much to that decision. A clear reason is more useful than a promise to uncover a hidden age.

What are the limits of the functional-medicine evidence?

Evidence for one element of care does not validate a whole care model. A study of personalised food advice, activity or a selected test cannot show that every approach offered under functional medicine improves healthspan. The claims should stay close to the research actually cited.

The What Is Functional Medicine? Evidence, Principles and Limits guide explains the broader evidence talk. Use it to ask which part of a plan is well supported, which is uncertain and which is optional. A service should be able to explain those differences without presenting uncertainty as a reason to buy more tests.

Patient stories also have limits. They can describe experiences but cannot control for other care, natural changes or the people who did not improve. A compelling account should not be treated as a personal prediction of how many healthy years you will gain.

What questions keep a prevention plan proportionate?

Ask what matters most, what can wait and how benefit will be judged. Agree who is in charge of results and follow-up. If a plan includes repeated testing, ask what change would trigger a useful action and what would happen if the result stayed the same.

The Longevity & Anti-Ageing Medicine in London page gives the broader visit context. Before booking, make clear the purpose, fee and possible extra costs. You should be able to talk about ageing-related goals without being committed in advance to a supplement package or experimental approach.

Keep the plan tied to your own priorities and established care. A worthwhile outcome might be clearer risk details, a manageable habit change or a decision not to pursue a low-value test. None needs to be presented as age reversal to be useful.